News Quantified

CMIIU – cm life sciences ii inc. - unit (US:NASDAQ)

Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales [Yahoo! Finance]

Columbus Circle Capital Corp II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 27, 2026

Columbus Circle Capital Corp II (NASDAQ:CMIIU) was upgraded by analysts at

Columbus Circle Capital Corp. II and Cohen & Company Inc. Announce Completion of $230,000,000 Initial Public Offering

Columbus Circle Capital Corp II Announces Pricing of $200,000,000 Initial Public Offering

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}